PLSE Q2 2023 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.22

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$75M

Total Liabilities

$14M

Stockholders' Equity

$61M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$265,000	-100.0%
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$10M	-$14M	+27.0%
Net Income	-$10M	-$14M	+29.2%